LUCENTIS Falls But Novartis Raises Outlook On Lower Than Expected Patent Hit

New Stories

• This exchange on the HTA Review was about as underwhelming as it sounds

  October 9, 2025 - - Latest News

• AusBiotech unveils international conference program for Australia’s biggest week in biotech

  October 9, 2025 - - Australian Biotech

• Life sciences industry calls for stronger national strategy to support trials and innovation

  October 9, 2025 - - Latest News

• Officials outline ongoing measures to address ADHD medicine shortages

  October 9, 2025 - - Latest News

• Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs

  October 9, 2025 - - Latest News

• Australian company reports positive outcome from collaboration

  October 8, 2025 - - Australian Biotech

• CUREator opens $33 million funding round with CSL and AbbVie partnership

  October 8, 2025 - - Latest News